Neuroreader®

Brainreader

Neuroreader® processes the MRI scans and provides a patient report with total brain volume, hippocampal volume and volumetric data on segments of the brain measured against a healthy database.

Information source: Vendor
Last updated: October 7, 2024

General Information

General
Product name	Neuroreader®
Company	Brainreader
Subspeciality	Neuro
Modality	MR
Disease targeted	Neurodegenerative disorders
Key-features	Brain region quantification, comparison to a normative database
Suggested use	Diagnostic aid

Technical Specifications

Data characteristics
Population	People with neurogenerative disorders
Input	3D, T1, weighted MPRAGE, 1 mm thickness (max 1.2 mm), without contrast (or procontrast)
Input format	DICOM
Output	Segmentation overlay, report with volume metrics
Output format	DICOM, secondary capture
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment	Locally on dedicated hardware, Cloud-based
Trigger for analysis	On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, Class I , MDD
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since	02-2015
Distribution channels	Blackford
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use
Based on

Evidence

Evidence
Peer reviewed papers on performance	Diagnostic utility of brain MRI volumetry in comparing traumatic brain injury, Alzheimer disease, and behavioral variant frontotemporal dementia (read) Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging (read)
Non-peer reviewed papers on performance
Other relevant papers